|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
130,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,187 |
Total Buy Value |
$0 |
$0 |
$0 |
$38,963 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
360,206 |
364,154 |
384,904 |
393,229 |
Total Sell Value |
$17,969,272 |
$18,139,637 |
$18,764,717 |
$18,997,752 |
Total People Sold |
6 |
6 |
6 |
6 |
Total Sell Transactions |
15 |
20 |
26 |
32 |
End Date |
2025-04-10 |
2025-01-07 |
2024-07-09 |
2023-07-10 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Joyce Meghan V. |
Director |
|
2025-07-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
66 |
11,216 |
|
- |
|
Eagle Craig |
Chief Medical Officer |
|
2025-07-01 |
4 |
D |
$50.71 |
$86,917 |
D/D |
(1,714) |
36,791 |
|
- |
|
Eagle Craig |
Chief Medical Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,381 |
38,505 |
|
- |
|
Eltoukhy Helmy |
Co-Chief Executive Officer |
|
2025-07-01 |
4 |
D |
$50.71 |
$616,735 |
D/D |
(12,162) |
2,423,499 |
|
- |
|
Eltoukhy Helmy |
Co-Chief Executive Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,997 |
2,435,661 |
|
- |
|
Kalia Kumud |
Chief Information Officer |
|
2025-07-01 |
4 |
D |
$50.71 |
$69,219 |
D/D |
(1,365) |
20,500 |
|
- |
|
Kalia Kumud |
Chief Information Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,691 |
21,865 |
|
- |
|
Freeman Chris |
Chief Commercial Officer |
|
2025-07-01 |
4 |
D |
$50.71 |
$77,688 |
D/D |
(1,532) |
48,821 |
|
- |
|
Freeman Chris |
Chief Commercial Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,596 |
50,353 |
|
- |
|
Chudova Darya |
Chief Technology Officer |
|
2025-07-01 |
4 |
D |
$50.71 |
$77,333 |
D/D |
(1,525) |
81,294 |
|
- |
|
Chudova Darya |
Chief Technology Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,007 |
82,819 |
|
- |
|
Saia John G. |
Chief Legal Officer |
|
2025-07-01 |
4 |
D |
$50.71 |
$70,284 |
D/D |
(1,386) |
44,823 |
|
- |
|
Saia John G. |
Chief Legal Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,641 |
46,209 |
|
- |
|
Bell Michael Brian |
Chief Financial Officer |
|
2025-07-01 |
4 |
D |
$50.71 |
$53,600 |
D/D |
(1,057) |
43,028 |
|
- |
|
Bell Michael Brian |
Chief Financial Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,084 |
44,085 |
|
- |
|
Talasaz Amirali |
Co-Chief Executive Officer |
|
2025-07-01 |
4 |
D |
$50.71 |
$616,735 |
D/D |
(12,162) |
1,983,665 |
|
- |
|
Talasaz Amirali |
Co-Chief Executive Officer |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,997 |
1,995,827 |
|
- |
|
Talasaz Amirali |
Co-Chief Executive Officer |
|
2025-07-01 |
4 |
AS |
$50.67 |
$5,087,630 |
D/D |
(100,000) |
1,971,830 |
|
- |
|
Eltoukhy Helmy |
Co-Chief Executive Officer |
|
2025-06-30 |
4 |
D |
$52.04 |
$127,030 |
D/D |
(2,441) |
2,411,664 |
|
- |
|
Eltoukhy Helmy |
Co-Chief Executive Officer |
|
2025-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,815 |
2,414,105 |
|
- |
|
Krognes Steve E. |
Director |
|
2025-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
17,819 |
|
- |
|
Talasaz Amirali |
Co-Chief Executive Officer |
|
2025-06-30 |
4 |
D |
$52.04 |
$127,030 |
D/D |
(2,441) |
2,071,830 |
|
- |
|
Talasaz Amirali |
Co-Chief Executive Officer |
|
2025-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,815 |
2,074,271 |
|
- |
|
Potter Myrtle S |
Director |
|
2025-06-18 |
4 |
S |
$49.47 |
$1,286 |
D/D |
(26) |
18,154 |
|
- |
|
Tariq Musa |
Director |
|
2025-06-18 |
4 |
S |
$49.47 |
$158,947 |
D/D |
(3,213) |
7,190 |
|
- |
|
974 Records found
|
|
Page 1 of 39 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|